TSX closed
Loading markets…
Stocks/NASDAQ/GEHC

GE HealthCare Technologies Inc. (GEHC : NASDAQ)

Common Stock

$79.55

USD

+2.98 (3.89%)

Last updated: 2026-11-02

💰

Dividend Declared

11 days ago

$0.0400 USD per share dividend. Ex-dividend date: October 23, 2026 • Payment date: November 13, 2026Upcoming

Follow GEHC

GEHC

GE HealthCare Technologies Inc.

Source:WealthAwesomeWealthAwesome
↑ $13.28 (20.04%)
30 day period
$63.98$71.77$79.55Sep 22Oct 13Nov 2

Performance

1 Day

+3.89%

1 Week

+10.52%

1 Month

+23.74%

YTD

-3.81%

Key Statistics

Market Cap

$35.97B

52W High

$89.59

52W Low

$58.68

P/E Ratio

16.82

50 Day MA

$68.45

200 Day MA

$69.82

Beta

0.77

Dividend Yield

0.19%

Technical Indicators

Price vs 50-Day SMA

↑Above 50 SMA

Price vs 200-Day SMA

↑Above 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
11/2/2026$77.54$80.34$77.38$79.55$79.554,768,478
10/30/2026$77.43$78.22$76.19$76.57$76.573,967,500
10/29/2026$76.20$77.33$75.40$76.42$76.424,635,820
10/28/2026$76.00$77.88$74.64$75.82$75.829,563,144
10/27/2026$71.73$71.80$70.17$71.11$71.115,053,679
10/26/2026$71.19$72.30$71.00$71.98$71.982,868,488
10/23/2026$70.74$71.86$70.09$71.45$71.452,976,100
10/22/2026$69.33$71.70$69.31$71.42$71.383,130,300
10/21/2026$69.02$70.26$68.70$69.01$69.012,182,500
10/20/2026$70.25$71.02$69.63$70.23$70.232,259,994

Analyst Price Targets

Based on 22 analysts covering GEHC · as of Nov 2, 2026

📈

Wall Street analysts forecast GEHC stock price to rise 10.0% over the next 12 months.

Consensus

Buy

4.18 / 5.00

Avg. Target

US$87.50

+10.0% Upside

Previously US$86.80 on Oct 30, 2026

Current Price

US$79.55

Last close

Analyst Breakdown (22 analysts)

Strong Buy 10
Buy 6
Hold 6
Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on GEHC's historical volatility

HistoricalForecast68%95%
US$58.76US$74.49US$90.22US$105.95US$121.68US$137.41TodayJun 26Aug 31Nov 2Dec 15Jan 28Mar 12

30-Day Vol

30.3%

Annualized

90-Day Vol

35.4%

Annualized

Trend (90d)

+43.2%

Annualized drift

90d Mean

US$92.83

Expected price

HorizonExpected68% Range (1σ)
30 trading daysUS$83.75US$75.43 – US$92.99
60 trading daysUS$88.17US$76.04 – US$102.24
90 trading daysUS$92.83US$77.43 – US$111.29

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About GE HealthCare Technologies Inc.

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company has a strategic collaboration with DeepHealth. GE HealthCare Technologies Inc. was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

Financials

Revenue (TTM)
$21.64B
EBITDA
$3.60B
Profit Margin
9.95%
ROE (TTM)
20.01%
EPS (Diluted)
4.73
Book Value
25.69

Classification

Sector
Health Care
Industry
Health Care Equipment & Supplies
Group
Health Care Equipment & Services

Recent Dividends

$0.0400USD

Ex: Oct 23, 2026

Pay: Nov 13

Quarterly

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Common Questions About GEHC.US

Market movers

Recent NASDAQ movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
VCIGVCI Global Limited Ordinary Share$8.16+4728.40%
RETOReTo Eco-Solutions Inc$4.16+647.26%
BJDXBluejay Diagnostics Inc$2.12+281.02%
INOInovio Pharmaceuticals Inc$1.89+215.00%
CLROClearOne Inc$5.65+65.69%
INLFINLIF LIMITED Ordinary Shares$0.29+56.76%
AMPGZAmplitech Group, Inc. Series B Right$0.06+55.50%
GENVRGen Digital Inc. Contingent Value Rights$2.85+52.41%

GEHC.US news timeline

14 articles covering GEHC.US, most recent first

Latest

GE HealthCare Introduces AI Imaging System for Cardiac Procedures: What Investors Should Know

•Stocks